GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Suzuken Co Ltd (TSE:9987) » Definitions » EV-to-EBITDA

Suzuken Co (TSE:9987) EV-to-EBITDA : 3.12 (As of May. 13, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Suzuken Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Suzuken Co's enterprise value is 円127,053 Mil. Suzuken Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was 円40,669 Mil. Therefore, Suzuken Co's EV-to-EBITDA for today is 3.12.

The historical rank and industry rank for Suzuken Co's EV-to-EBITDA or its related term are showing as below:

TSE:9987' s EV-to-EBITDA Range Over the Past 10 Years
Min: 0.55   Med: 5.26   Max: 13.21
Current: 3.12

During the past 13 years, the highest EV-to-EBITDA of Suzuken Co was 13.21. The lowest was 0.55. And the median was 5.26.

TSE:9987's EV-to-EBITDA is ranked better than
90.12% of 81 companies
in the Medical Distribution industry
Industry Median: 10.41 vs TSE:9987: 3.12

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-13), Suzuken Co's stock price is 円4693.00. Suzuken Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円336.699. Therefore, Suzuken Co's PE Ratio for today is 13.94.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Suzuken Co EV-to-EBITDA Historical Data

The historical data trend for Suzuken Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzuken Co EV-to-EBITDA Chart

Suzuken Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.70 2.67 7.66 3.68 2.15

Suzuken Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.45 2.15 4.24 2.84 3.06

Competitive Comparison of Suzuken Co's EV-to-EBITDA

For the Medical Distribution subindustry, Suzuken Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzuken Co's EV-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Suzuken Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Suzuken Co's EV-to-EBITDA falls into.



Suzuken Co EV-to-EBITDA Calculation

Suzuken Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=127053.045/40669
=3.12

Suzuken Co's current Enterprise Value is 円127,053 Mil.
Suzuken Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円40,669 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Suzuken Co  (TSE:9987) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Suzuken Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4693.00/336.699
=13.94

Suzuken Co's share price for today is 円4693.00.
Suzuken Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円336.699.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Suzuken Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Suzuken Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Suzuken Co (TSE:9987) Business Description

Traded in Other Exchanges
N/A
Address
8 Higashi Kataha-machi, Higashi-ku, Nagoya, JPN, 461-8701
Suzuken Co Ltd is a Japanese drug manufacturer. It functions through four segments: Pharmaceutical Wholesale, which sells pharmaceuticals, diagnostic drugs, and medical equipment and materials; The Pharmaceutical Manufacturing, which produces pharmaceuticals and diagnostic drugs; The Insurance Pharmacy dispenses operations based on prescriptions from medical institutions and the Medical-related Service and Others segment which sells medical books, provides nursing services and manufactures physiological examination equipment.

Suzuken Co (TSE:9987) Headlines

No Headlines